Literature DB >> 24367285

A relationship between Pseudomonal growth behaviour and cystic fibrosis patient lung function identified in a metabolomic investigation.

Justyna Kozlowska1, Damian W Rivett1, Louic S Vermeer1, Mary P Carroll2, Kenneth D Bruce1, A James Mason1, Geraint B Rogers1.   

Abstract

Chronic polymicrobial lung infections in adult cystic fibrosis patients are typically dominated by high levels of Pseudomonas aeruginosa. Determining the impact of P. aeruginosa growth on airway secretion composition is fundamental to understanding both the behaviour of this pathogen in vivo, and its relationship with other potential colonising species. We hypothesised that the marked differences in the phenotypes of clinical isolates would be reflected in the metabolite composition of spent culture media. 1H NMR spectroscopy was used to characterise the impact of P. aeruginosa growth on a synthetic medium as part of an in vitro CF lower airways model system. Comparisons of 15 CF clinical isolates were made and four distinct metabolomic clusters identified. Highly significant relationships between P. aeruginosa isolate cluster membership and both patient lung function (FEV1) and spent culture pH were identified. This link between clinical isolate growth behaviour and FEV1 indicates characterisation of P. aeruginosa growth may find application in predicting patient lung function while the significant divergence in metabolite production and consumption observed between CF clinical isolates suggests dominant isolate characteristics have the potential to play both a selective role in microbiota composition and influence pseudomonal behaviour in vivo.

Entities:  

Keywords:  NMR; Pseudomonal; cystic fibrosis; lung function

Year:  2013        PMID: 24367285      PMCID: PMC3868936          DOI: 10.1007/s11306-013-0538-5

Source DB:  PubMed          Journal:  Metabolomics        ISSN: 1573-3882            Impact factor:   4.290


  49 in total

1.  Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis.

Authors:  M M Tunney; E R Klem; A A Fodor; D F Gilpin; T F Moriarty; S J McGrath; M S Muhlebach; R C Boucher; C Cardwell; G Doering; J S Elborn; M C Wolfgang
Journal:  Thorax       Date:  2011-01-26       Impact factor: 9.139

2.  Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics.

Authors:  Frank Dieterle; Alfred Ross; Götz Schlotterbeck; Hans Senn
Journal:  Anal Chem       Date:  2006-07-01       Impact factor: 6.986

3.  Microbial diversity in the sputum of a cystic fibrosis patient studied with 16S rDNA pyrosequencing.

Authors:  F Armougom; F Bittar; N Stremler; J-M Rolain; C Robert; J-C Dubus; J Sarles; D Raoult; B La Scola
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-05-16       Impact factor: 3.267

4.  Influence of external pH on ciliary beat frequency in human bronchi and bronchioles.

Authors:  C Clary-Meinesz; J Mouroux; J Cosson; P Huitorel; B Blaive
Journal:  Eur Respir J       Date:  1998-02       Impact factor: 16.671

5.  pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon.

Authors:  Alan W Walker; Sylvia H Duncan; E Carol McWilliam Leitch; Matthew W Child; Harry J Flint
Journal:  Appl Environ Microbiol       Date:  2005-07       Impact factor: 4.792

6.  Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience.

Authors:  Franziska Anne Stressmann; Geraint B Rogers; Christopher J van der Gast; Peter Marsh; Louic S Vermeer; Mary P Carroll; Lucas Hoffman; Thomas W V Daniels; Nilesh Patel; Benjamin Forbes; Kenneth Deans Bruce
Journal:  Thorax       Date:  2012-06-15       Impact factor: 9.139

7.  Regulation of arginine acquisition and virulence gene expression in the human pathogen Streptococcus pneumoniae by transcription regulators ArgR1 and AhrC.

Authors:  Tomas G Kloosterman; Oscar P Kuipers
Journal:  J Biol Chem       Date:  2011-11-14       Impact factor: 5.157

Review 8.  Phenotypes selected during chronic lung infection in cystic fibrosis patients: implications for the treatment of Pseudomonas aeruginosa biofilm infections.

Authors:  Oana Ciofu; Lotte F Mandsberg; Hengzhuang Wang; Niels Høiby
Journal:  FEMS Immunol Med Microbiol       Date:  2012-06-01

9.  Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis.

Authors:  M Kolpen; C R Hansen; T Bjarnsholt; C Moser; L D Christensen; M van Gennip; O Ciofu; L Mandsberg; A Kharazmi; G Döring; M Givskov; N Høiby; P Ø Jensen
Journal:  Thorax       Date:  2009-10-21       Impact factor: 9.139

10.  THE GENUS VEILLONELLA . II. NUTRITIONAL STUDIES.

Authors:  M ROGOSA; F S BISHOP
Journal:  J Bacteriol       Date:  1964-03       Impact factor: 3.490

View more
  9 in total

1.  Impact of storage conditions on metabolite profiles of sputum samples from persons with cystic fibrosis.

Authors:  Jiangchao Zhao; Charles R Evans; Lisa A Carmody; John J LiPuma
Journal:  J Cyst Fibros       Date:  2015-02-26       Impact factor: 5.482

2.  Predominant pathogen competition and core microbiota divergence in chronic airway infection.

Authors:  Geraint B Rogers; Christopher J van der Gast; David J Serisier
Journal:  ISME J       Date:  2014-07-18       Impact factor: 10.302

3.  Effects of tobacco smoke and electronic cigarette vapor exposure on the oral and gut microbiota in humans: a pilot study.

Authors:  Christopher J Stewart; Thomas A Auchtung; Nadim J Ajami; Kenia Velasquez; Daniel P Smith; Richard De La Garza; Ramiro Salas; Joseph F Petrosino
Journal:  PeerJ       Date:  2018-04-30       Impact factor: 2.984

4.  Single-Cell RNA-Sequencing and Metabolomics Analyses Reveal the Contribution of Perivascular Adipose Tissue Stem Cells to Vascular Remodeling.

Authors:  Wenduo Gu; Witold N Nowak; Yao Xie; Alexandra Le Bras; Yanhua Hu; Jiacheng Deng; Shirin Issa Bhaloo; Yao Lu; Hong Yuan; Efthymios Fidanis; Alka Saxena; Tokuwa Kanno; A James Mason; Jozef Dulak; Jingjing Cai; Qingbo Xu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-07-25       Impact factor: 8.311

Review 5.  Metabolomic studies of Pseudomonas aeruginosa.

Authors:  Karolina Anna Mielko; Sławomir Jan Jabłoński; Justyna Milczewska; Dorota Sands; Marcin Łukaszewicz; Piotr Młynarz
Journal:  World J Microbiol Biotechnol       Date:  2019-11-07       Impact factor: 3.312

Review 6.  Potential of metabolomics to reveal Burkholderia cepacia complex pathogenesis and antibiotic resistance.

Authors:  Nusrat S Shommu; Hans J Vogel; Douglas G Storey
Journal:  Front Microbiol       Date:  2015-07-13       Impact factor: 5.640

7.  Lessons learned from metabolomics in cystic fibrosis.

Authors:  Marianne S Muhlebach; Wei Sha
Journal:  Mol Cell Pediatr       Date:  2015-10-20

8.  Correlation of the lung microbiota with metabolic profiles in bronchoalveolar lavage fluid in HIV infection.

Authors:  Sushma K Cribbs; Karan Uppal; Shuzhao Li; Dean P Jones; Laurence Huang; Laura Tipton; Adam Fitch; Ruth M Greenblatt; Lawrence Kingsley; David M Guidot; Elodie Ghedin; Alison Morris
Journal:  Microbiome       Date:  2016-01-20       Impact factor: 14.650

9.  Convergent Metabolic Specialization through Distinct Evolutionary Paths in Pseudomonas aeruginosa.

Authors:  Ruggero La Rosa; Helle Krogh Johansen; Søren Molin
Journal:  mBio       Date:  2018-04-10       Impact factor: 7.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.